4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001992324-25-000005
CFO & CBO sold 20,000 shares at $45.18 ($903,600)
- CFO & CBO acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Savitz Ryan CFO & CBO | 2025-12-04 | Option exercise 10b5-1 | +20,000 | $8.44 | $168,800 | 20,000 | D |
| Savitz Ryan CFO & CBO | 2025-12-04 | Sale 10b5-1 | −20,000 | $45.18 | $903,600 | 0 | D |
| Derivatives | |||||||
| Savitz Ryan CFO & CBO | 2025-12-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +20,000 | 84,766 | D | ||
| Open-market sales · 20,000 sh · avg $45.18 · $903,600 | |||||||
Loading xslF345X05/ownership.xml…